Predictive factors for successful renal denervation: should we use them in clinical trials?
Identifieur interne : 000573 ( Main/Exploration ); précédent : 000572; suivant : 000574Predictive factors for successful renal denervation: should we use them in clinical trials?
Auteurs : Nicolas Barber-Chamoux [France] ; Murray D. Esler [Australie]Source :
- European journal of clinical investigation [ 1365-2362 ] ; 2017.
Abstract
Renal denervation (RDN) is facing various challenges to its initial claimed value in hypertension treatment. Major concerns are the choice of the patients and the technical efficacy of the RDN. Different factors have been described as predicting the capacity of RDN to decrease blood pressure. These factors are related to the patients, the procedure and the tools to confirm successful neural ablation. Their use in future trials should help to improve RDN trials understanding and outcomes. This review summarizes the different predictive factors available and their potential benefits in patient selection and in procedure guidance.
DOI: 10.1111/eci.12792
PubMed: 28771706
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000093
- to stream PubMed, to step Curation: 000093
- to stream PubMed, to step Checkpoint: 000093
- to stream Ncbi, to step Merge: 004C32
- to stream Ncbi, to step Curation: 004C32
- to stream Ncbi, to step Checkpoint: 004C32
- to stream Main, to step Merge: 000568
- to stream Main, to step Curation: 000573
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Predictive factors for successful renal denervation: should we use them in clinical trials?</title><author><name sortKey="Barber Chamoux, Nicolas" sort="Barber Chamoux, Nicolas" uniqKey="Barber Chamoux N" first="Nicolas" last="Barber-Chamoux">Nicolas Barber-Chamoux</name><affiliation wicri:level="3"><nlm:affiliation>Cardiology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Cardiology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation></author><author><name sortKey="Esler, Murray D" sort="Esler, Murray D" uniqKey="Esler M" first="Murray D" last="Esler">Murray D. Esler</name><affiliation wicri:level="1"><nlm:affiliation>Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Vic., Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Vic.</wicri:regionArea><wicri:noRegion>Vic.</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28771706</idno><idno type="pmid">28771706</idno><idno type="doi">10.1111/eci.12792</idno><idno type="wicri:Area/PubMed/Corpus">000093</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000093</idno><idno type="wicri:Area/PubMed/Curation">000093</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000093</idno><idno type="wicri:Area/PubMed/Checkpoint">000093</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000093</idno><idno type="wicri:Area/Ncbi/Merge">004C32</idno><idno type="wicri:Area/Ncbi/Curation">004C32</idno><idno type="wicri:Area/Ncbi/Checkpoint">004C32</idno><idno type="wicri:Area/Main/Merge">000568</idno><idno type="wicri:Area/Main/Curation">000573</idno><idno type="wicri:Area/Main/Exploration">000573</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Predictive factors for successful renal denervation: should we use them in clinical trials?</title><author><name sortKey="Barber Chamoux, Nicolas" sort="Barber Chamoux, Nicolas" uniqKey="Barber Chamoux N" first="Nicolas" last="Barber-Chamoux">Nicolas Barber-Chamoux</name><affiliation wicri:level="3"><nlm:affiliation>Cardiology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Cardiology Department, Clermont-Ferrand University Hospital, Clermont-Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation></author><author><name sortKey="Esler, Murray D" sort="Esler, Murray D" uniqKey="Esler M" first="Murray D" last="Esler">Murray D. Esler</name><affiliation wicri:level="1"><nlm:affiliation>Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Vic., Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Vic.</wicri:regionArea><wicri:noRegion>Vic.</wicri:noRegion></affiliation></author></analytic><series><title level="j">European journal of clinical investigation</title><idno type="eISSN">1365-2362</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Renal denervation (RDN) is facing various challenges to its initial claimed value in hypertension treatment. Major concerns are the choice of the patients and the technical efficacy of the RDN. Different factors have been described as predicting the capacity of RDN to decrease blood pressure. These factors are related to the patients, the procedure and the tools to confirm successful neural ablation. Their use in future trials should help to improve RDN trials understanding and outcomes. This review summarizes the different predictive factors available and their potential benefits in patient selection and in procedure guidance.</div></front></TEI><affiliations><list><country><li>Australie</li><li>France</li></country><region><li>Auvergne (région administrative)</li><li>Auvergne-Rhône-Alpes</li></region><settlement><li>Clermont-Ferrand</li></settlement></list><tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Barber Chamoux, Nicolas" sort="Barber Chamoux, Nicolas" uniqKey="Barber Chamoux N" first="Nicolas" last="Barber-Chamoux">Nicolas Barber-Chamoux</name></region></country><country name="Australie"><noRegion><name sortKey="Esler, Murray D" sort="Esler, Murray D" uniqKey="Esler M" first="Murray D" last="Esler">Murray D. Esler</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000573 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000573 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28771706
|texte= Predictive factors for successful renal denervation: should we use them in clinical trials?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28771706" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |